BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 334674)

  • 1. A review of the medical considerations of the use of tylosin and other macrolide antibiotics as additives in animal feeds.
    Knothe H
    Infection; 1977; 5(3):183-7. PubMed ID: 334674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical implications of macrolide resistance and its relationship to the use of tylosin in animal feeds.
    Knothe H
    Infection; 1977; 5(3):137-9. PubMed ID: 914361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tylosin feeding on the antibiotic resistance of selected gram-positive bacteria in pigs.
    Christie PJ; Davidson JN; Novick RP; Dunny GM
    Am J Vet Res; 1983 Jan; 44(1):126-8. PubMed ID: 6824216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tylosin used as a growth promoter on the occurrence of macrolide-resistant enterococci and staphylococci in pigs.
    Aarestrup FM; Carstensen B
    Microb Drug Resist; 1998; 4(4):307-12. PubMed ID: 9988049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the effects of 3-acetyl-4"-isovaleryltylosin against multiple-drug resistant strains of Staphylococcus aureus.
    Tsuchiya M; Suzukake K; Hori M; Sawa T; Takeuchi T; Umezawa H; Okamoto R; Nomura H; Tsunekawa H; Inui T
    J Antibiot (Tokyo); 1981 Mar; 34(3):305-12. PubMed ID: 7275812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rarity of gene transfer between animal and human isolates of Staphylococcus aureus in vitro.
    Lacey RW
    J Gen Microbiol; 1980 Aug; 119(2):437-42. PubMed ID: 6453205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rarity of tylosin resistance in human pathogenic bacteria.
    Lacey RW
    Vet Rec; 1988 Apr; 122(18):438-9. PubMed ID: 3293307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of tylosin derivatives effective against macrolide-resistant strains: synthesis and structure-activity relationships.
    Tsuchiya M; Hamada M; Takeuchi T; Umezawa H; Yamamoto K; Tanaka H; Kiyoshima K; Mori S; Okamoto R
    J Antibiot (Tokyo); 1982 Jun; 35(6):661-72. PubMed ID: 7118722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility and resistance of animal staphylococci to macrolide antibiotics and related compounds.
    Devriese LA
    Ann Rech Vet; 1976; 7(1):65-74. PubMed ID: 136223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tylosin susceptibility of Staphylococci from bovine mastitis.
    Entorf M; Feßler AT; Kadlec K; Kaspar H; Mankertz J; Peters T; Schwarz S
    Vet Microbiol; 2014 Jul; 171(3-4):368-73. PubMed ID: 24461550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of 3-O-acetyl-4"-O-isovaleryltylosin to ribosomes from a macrolide-resistant strain of Staphylococcus aureus.
    Tsuchiya M; Sawa T; Takeuchi T; Umezawa H; Okamoto R
    J Antibiot (Tokyo); 1982 Jun; 35(6):673-9. PubMed ID: 7118723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turbidimetric assay of tylosin in animal feeds containing urea.
    Coleman MR; Mowrey DH
    J Assoc Off Anal Chem; 1990; 73(6):927-31. PubMed ID: 2289924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative erythromycin and tylosin susceptibility testing of streptococci from bovine mastitis.
    Entorf M; Feßler AT; Kaspar H; Kadlec K; Peters T; Schwarz S
    Vet Microbiol; 2016 Oct; 194():36-42. PubMed ID: 26732695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antibacterial activity of a novel class of 4'-substituted 16-membered ring macrolides derived from tylosin.
    Phan LT; Jian T; Chen Z; Qiu YL; Wang Z; Beach T; Polemeropoulos A; Or YS
    J Med Chem; 2004 Jun; 47(12):2965-8. PubMed ID: 15163176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of evidence for mutation to erythromycin resistance in clinical strains of Staphylococcus aureus.
    Lacey RW
    J Clin Pathol; 1977 Jul; 30(7):602-5. PubMed ID: 886013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance of staphylococci. IX. Inducible resistance to macrolide antibiotics in Staphylococcus aureus.
    Hashimoto H; Oshima H; Mitsuhashi S
    Jpn J Microbiol; 1968 Sep; 12(3):321-7. PubMed ID: 4236812
    [No Abstract]   [Full Text] [Related]  

  • 17. Sub-inhibitory and post-antibiotic effects of spiramycin and erythromycin on Staphylococcus aureus.
    Webster C; Ghazanfar K; Slack R
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():33-9. PubMed ID: 3182445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode of action of the protein, SP127, which enhances the activity of macrolide antibiotics against Pseudomonas aeruginosa.
    Kikuchi M; Nakao Y
    J Antibiot (Tokyo); 1977 Mar; 30(3):215-20. PubMed ID: 405356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of a determinant mediating partial macrolide resistance in Staphylococcus aureus.
    Matsuoka M; Endou K; Nakajima Y
    Microbiol Immunol; 1990; 34(8):643-52. PubMed ID: 2126334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece.
    Vallianou N; Evangelopoulos A; Hadjisoteriou M; Avlami A; Petrikkos G
    J Chemother; 2015; 27(6):319-23. PubMed ID: 25112954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.